DOI: 10.1515/mr-2023-0070
New era of cancer immunology driven by big data
Chunhong Zheng1
Zemin Zhang2
1.Peking University International Cancer Institute,Peking University Cancer Hospital and Institute,Health Science Center,Peking University,Beijing,China2.BIOPIC,Beijing Advanced Innovation Center for Genomics,School of Life Sciences,Peking-Tsinghua Center for Life Sciences,Peking University,Yiheyuan Road#5,Beijing 100871,China
摘要：Cancer immunology has witnessed remarkable development over the past century. In the early 20th century, William Coley embarked on pioneering efforts to activate the immune sys-tem against cancer using heat-killed Streptococcus pyogenes and Serratia marcescens [1]. These attempts yielded varying clinical outcomes, some of which were notably successful, providing early evidence of the immune system's potential in combating cancer. Moving into the mid-20th century, Dr. Lewis Thomas and Dr. Macfarlane Burnet introduced the concept "immune surveillance" [2].
机标关键词：cancerdatadrivenimmunology
论文发表日期：2023-12-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：3( 449-451 )